Zacks Investment Management »

Heron Therapeutics shares owned by Zacks Investment Management

Quarter-by-quarter ownership of Heron Therapeutics (HRTX) shares owned by Zacks Investment Management from 13F filings

Historical chart of Zacks Investment Management investment in Heron Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Heron Therapeutics held by Zacks Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Heron Therapeutics by Zacks Investment Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $946k 476k 1.99
2024-06-30 $1.6M 464k 3.50
2024-03-31 $1.2M 437k 2.77
2023-12-31 $529k 311k 1.70